EtiraRX, Inc.

Form D Filings

Location
Dallas, TX
Industry Group
Biotechnology
Entity Type
Corporation
CIK
0001996442
All SEC Filings
View on sec.gov
Date Filed Security Types Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
5/13/2026 Equity $2,277,533 $3,000,003 $722,470 4/17/2026 5/13/2026 D 000199644226000002
6/23/2025 Equity $2,399,987 $4,869,987 $2,470,000 6/6/2025 6/23/2025 D 000199644225000002
10/5/2023 Equity $4,820,140 $10,595,149 $5,775,009 9/15/2023 10/5/2023 D 000199644223000001